Cowealth Medical Holding Co Ltd (4745) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cowealth Medical Holding Co Ltd (4745) has a cash flow conversion efficiency ratio of -0.067x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-342.75 Million ≈ $-10.80 Million USD) by net assets (NT$5.14 Billion ≈ $161.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Cowealth Medical Holding Co Ltd for the company's overall valuation and market capitalisation.
Cowealth Medical Holding Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Cowealth Medical Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cowealth Medical Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cowealth Medical Holding Co Ltd ranked by their cash flow conversion efficiency. Explore Cowealth Medical Holding Co Ltd (4745) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PPK Group Ltd
AU:PPK
|
-0.034x |
|
Catena Media plc
ST:CTM
|
0.055x |
|
S2 Resources Ltd
AU:S2R
|
-0.100x |
|
Flap Kongre Toplanti Hizmetleri Otomotiv ve Turizm AS
IS:FLAP
|
-0.004x |
|
SABUY TECHNOLOGY
BK:SABUY-R
|
N/A |
|
Scandinavian Investment Group A/S
CO:SIG
|
0.046x |
|
Local Bounti Corp
NYSE:LOCL
|
0.034x |
|
Nara Mold & Die Co. Ltd
KQ:051490
|
-0.010x |
Annual Cash Flow Conversion Efficiency for Cowealth Medical Holding Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of Cowealth Medical Holding Co Ltd from 2017 to 2025. View Cowealth Medical Holding Co Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$5.06 Billion ≈ $159.31 Million |
NT$15.53 Million ≈ $489.28K |
0.003x | -96.60% |
| 2024-12-31 | NT$5.19 Billion ≈ $163.65 Million |
NT$469.43 Million ≈ $14.79 Million |
0.090x | +909.36% |
| 2023-12-31 | NT$5.03 Billion ≈ $158.42 Million |
NT$45.02 Million ≈ $1.42 Million |
0.009x | +117.41% |
| 2022-12-31 | NT$5.20 Billion ≈ $163.89 Million |
NT$-267.59 Million ≈ $-8.43 Million |
-0.051x | -53.18% |
| 2021-12-31 | NT$3.53 Billion ≈ $111.06 Million |
NT$-118.38 Million ≈ $-3.73 Million |
-0.034x | -114.32% |
| 2020-12-31 | NT$3.43 Billion ≈ $108.10 Million |
NT$804.75 Million ≈ $25.35 Million |
0.235x | +673.55% |
| 2019-12-31 | NT$3.34 Billion ≈ $105.38 Million |
NT$-136.78 Million ≈ $-4.31 Million |
-0.041x | -157.89% |
| 2018-12-31 | NT$1.89 Billion ≈ $59.60 Million |
NT$133.64 Million ≈ $4.21 Million |
0.071x | -13.07% |
| 2017-12-31 | NT$1.66 Billion ≈ $52.44 Million |
NT$135.26 Million ≈ $4.26 Million |
0.081x | -- |
About Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more